VPH — Valeo Pharma Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- CA$4.44m
- CA$67.40m
- CA$53.91m
Brief: Valeo Pharma Amends Credit Facility With Sagard Healthcare Royalty Partners
Brief: Valeo Pharma Announces Restructuring Of Commercial Field Operations To Support Path To Profitability
Brief: Valeo Pharma Announces Appointment Of Mr. Al Moghaddam To Board Of Directors
Brief: Valeo Pharma Amends Agreement With Novartis Pharmaceuticals Canada
Brief: Valeo Pharma Announces Organizational Changes And Cost Reduction Initiatives
Brief: Valeo Pharma Announces Appointment Of Richard Lajoie To Board Of Directors
Brief: Valeo Pharma Provides Update On Ophthalmology Business Unit
Brief: Valeo Pharma Announces New Board Appointments
Brief: Valeo Pharma Reports Record Quarterly Revenues For The Q1 2023
Brief: Valeo Pharma Obtains Public Reimbursement For Onstryv® In Quebec
Brief: Valeo Pharma Reports Record Quarterly And Annual Revenues For Q4 And The Fiscal Year 2022
Brief: Valeo Pharma Files New Drug Submission-Covid 19 With Health Canada
Brief: Valeo Pharma Announces Senior Management Change
Brief: Valeo Pharma Inc Sees Q4 Revenue Up 14 To 18 Percent
Brief: Valeo Pharma Enters Into Canadian Commercial Services Agreement With Veru For Sabizabulin In Hospitalized Adult Patients With Covid-19
Brief: Valeo Pharma Reports Revenue Up 7% To C$6.1 Mln
Brief: Valeo Pharma Enters Into An Agreement For Ophthalmic Products, Prxiidra® And Prsimbrinza®, In Canada
Brief: Valeo Pharma Reports Its Second Quarter 2022 Results And Highlights
Brief: Valeo Pharma Announces Listing To The Toronto Stock Exchange